JP2009521707A5 - - Google Patents

Download PDF

Info

Publication number
JP2009521707A5
JP2009521707A5 JP2008548837A JP2008548837A JP2009521707A5 JP 2009521707 A5 JP2009521707 A5 JP 2009521707A5 JP 2008548837 A JP2008548837 A JP 2008548837A JP 2008548837 A JP2008548837 A JP 2008548837A JP 2009521707 A5 JP2009521707 A5 JP 2009521707A5
Authority
JP
Japan
Prior art keywords
seq
sequence number
infected
detection
probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008548837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009521707A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/062632 external-priority patent/WO2007120362A2/en
Publication of JP2009521707A publication Critical patent/JP2009521707A/ja
Publication of JP2009521707A5 publication Critical patent/JP2009521707A5/ja
Pending legal-status Critical Current

Links

JP2008548837A 2005-12-27 2006-12-27 疾患のバイオマーカーとしての脂肪生成アデノウイルス Pending JP2009521707A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75340205P 2005-12-27 2005-12-27
PCT/US2006/062632 WO2007120362A2 (en) 2005-12-27 2006-12-27 Adipogenic adenoviruses as a biomarker for disease

Publications (2)

Publication Number Publication Date
JP2009521707A JP2009521707A (ja) 2009-06-04
JP2009521707A5 true JP2009521707A5 (https=) 2009-09-10

Family

ID=38610014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008548837A Pending JP2009521707A (ja) 2005-12-27 2006-12-27 疾患のバイオマーカーとしての脂肪生成アデノウイルス

Country Status (11)

Country Link
US (5) US7442511B2 (https=)
EP (2) EP1977009B1 (https=)
JP (1) JP2009521707A (https=)
KR (1) KR20080114683A (https=)
CN (1) CN101389768B (https=)
AU (1) AU2006342053A1 (https=)
BR (1) BRPI0620755A2 (https=)
CA (1) CA2635269A1 (https=)
MX (1) MX2008008453A (https=)
RU (1) RU2008130893A (https=)
WO (1) WO2007120362A2 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7507418B2 (en) * 2005-09-09 2009-03-24 Obetech, Llc Adenovirus status as a predictor of body composition change, disease status, and treatment outcomes
AU2006342053A1 (en) * 2005-12-27 2007-10-25 Obetech, Llc Adipogenic adenoviruses as a biomarker for disease
US20120082659A1 (en) * 2007-10-02 2012-04-05 Hartmut Land Methods And Compositions Related To Synergistic Responses To Oncogenic Mutations
JP2009156254A (ja) * 2007-12-05 2009-07-16 Ibiden Co Ltd 排気ガス処理体の保持シール部材及び排気ガス処理装置
PT2268618E (pt) 2008-03-03 2015-10-12 Novartis Ag Compostos e composições moduladores da actividade tlr
WO2010011440A2 (en) * 2008-06-16 2010-01-28 Obetech Llc Diagnosis and treatment of lipogenic adenovirus infection associated with adipose tissue hypertrophy
CA2765112A1 (en) 2009-06-10 2010-12-16 Novartis Ag Benzonaphthyridine-containing vaccines
ES2443952T3 (es) 2009-09-02 2014-02-21 Novartis Ag Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
US20120244187A1 (en) * 2009-10-22 2012-09-27 Atkinson Richard L Adenovirus Infection In Animals
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
US8591412B2 (en) 2009-11-18 2013-11-26 Nohands, Llc Method and system for preventing virus-related obesity and obesity related diseases
SG10201501980SA (en) 2009-12-15 2015-05-28 Novartis Ag Homogeneous suspension of immunopotentiating compounds and uses thereof
AU2011232421B2 (en) 2010-03-23 2015-08-13 Novartis Ag Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc.
US20130052635A1 (en) * 2010-03-25 2013-02-28 Richard L. Atkinson Method For Detecting Lipogenic Adenovirus
US9192661B2 (en) 2010-07-06 2015-11-24 Novartis Ag Delivery of self-replicating RNA using biodegradable polymer particles
KR101831638B1 (ko) * 2010-07-08 2018-02-23 보드 오브 슈퍼바이저스 오브 루이지애나 스테이트 유니버시티 앤드 애그리컬추얼 앤드 메카니컬 컬리지 비-알코올성 지방간 질환의 예방 및 치료를 위한 아데노바이러스 ad36 e4orf1 단백질
WO2012006550A2 (en) * 2010-07-09 2012-01-12 Obetech Llc Methods and compositions for treatment of lipogenic virus related conditions
US9254320B2 (en) 2010-12-17 2016-02-09 Globeimmune, Inc. Compositions and methods for the treatment or prevention of human adenovirus-36 infection
JP6411378B2 (ja) 2013-02-01 2018-10-24 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Ｔｏｌｌ様受容体アゴニストを含む免疫学的組成物の皮内送達
CA2966754A1 (en) 2014-11-05 2016-05-12 The United States Of America As Represented By The Secretary Of The Navy Synthetic antigen constructs against campylobacter jejuni
ES2985591T3 (es) 2018-02-12 2024-11-06 Inimmune Corp Ligandos de receptores tipo Toll
AU2019352906B2 (en) * 2018-10-05 2026-01-22 Minomic International Ltd. Biomarker combinations for determining aggressive prostate cancer
KR20230098825A (ko) 2020-11-04 2023-07-04 엘리고 바이오사이언스 씨. 아크네스 개체군에게 dna 페이로드의 원위치 전달을 위한 파지-유래 입자

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0689551B1 (en) * 1993-03-17 2008-02-20 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
WO1998044946A1 (en) * 1997-04-04 1998-10-15 Obetech, Llc Viral obesity methods and compositions
JP2000072800A (ja) * 1998-08-26 2000-03-07 Toagosei Co Ltd 抗アデノウイルス３７型モノクローナル抗体及びその用途
WO2007064836A1 (en) * 2005-11-30 2007-06-07 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Adenovirus 36 e4 orf 1 gene and protein and their uses
AU2006342053A1 (en) * 2005-12-27 2007-10-25 Obetech, Llc Adipogenic adenoviruses as a biomarker for disease

Similar Documents

Publication Publication Date Title
JP2009521707A5 (https=)
JP6542797B2 (ja) 標的の増幅およびマイクロアレイ検出を集積したマイクロ流体装置
WO2009061783A3 (en) Dna microarray having hairpin probes tethered to nanostructured metal surface
JP2008532485A5 (https=)
Toriello et al. Multichannel reverse transcription-polymerase chain reaction microdevice for rapid gene expression and biomarker analysis
KR20210104835A (ko) 분자 진단을 위한 장치 및 방법
EP2021516A4 (en) NUCLEIC ACID PRIMERS AND PROBES FOR THE DETECTION OF INFLUENZA VIRUSES OF PEOPLE AND BIRDS
JP2007534308A5 (https=)
DE60020124D1 (de) Verlängerung einer pna-dna chimäre an ihrem 3' ende mittels einer polymerase
JP2015156872A5 (https=)
Sun et al. A lab-on-a-chip device for rapid identification of avian influenza viral RNA by solid-phase PCR
WO2007041342A3 (en) Labeled nucleotide analogs and uses therefor
WO2008001376A3 (en) Detection of analytes in a medium
Teng et al. Specific detection of reverse transcription-loop-mediated isothermal amplification amplicons for Taura syndrome virus by colorimetric dot–blot hybridization
RU2019137083A (ru) Линкеры в виде короткой боковой ручки для нуклеотидов в областях применения секвенирования
JP2005530695A5 (https=)
WO2019073049A1 (en) ISOTHERMIC AMPLIFICATION IN SOLID PHASE
JP2009518001A5 (https=)
JP2012519003A5 (https=)
JP2014083052A5 (https=)
CN103866047B (zh) 用于检测h7n9亚型流感病毒的引物组合及检测试剂盒
CN1548545A (zh) 一种用于多靶序列pcr检测的公共引物及其对多靶核酸序列进行pcr扩增的方法
CN106498077B (zh) Dna扩增产物快速检测方法
WO2006116303A3 (en) Fluorescent multiplex hpv pcr assays
MD3300F1 (en) Oligonucleotide primer for hepatitis C virus RNA detection